The Future of Nephrology and Public Health.


Journal

Contributions to nephrology
ISSN: 1662-2782
Titre abrégé: Contrib Nephrol
Pays: Switzerland
ID NLM: 7513582

Informations de publication

Date de publication:
2021
Historique:
received: 31 03 2021
accepted: 02 06 2021
pubmed: 4 8 2021
medline: 2 4 2022
entrez: 3 8 2021
Statut: ppublish

Résumé

The study of kidney diseases has been described since the Hippocratic era, but nephrology as a medical specialty dates from the mid-20th century. Despite all interesting aspects of nephrology, there is a lack of interest by young physicians for the specialty worldwide. Great discoveries have been made throughout the years, leading to great achievements in diagnosis, classification, and treatment of kidney diseases. There is a current interest in the search for novel biomarkers for early detection of kidney dysfunction, and, in the future, there will be novel diagnostic tests for kidney diseases. There have been significant improvements in dialysis and transplant techniques, and novel modalities are being studied, including new renal replacement therapy modalities, such as the wearable artificial kidney. Another trend in the contemporary world, and one that should increase in the future, is the increasing patient connectivity, using novel technologies that will allow access to healthcare and improve outcomes.

Identifiants

pubmed: 34344005
pii: 000517714
doi: 10.1159/000517714
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

339-350

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Geraldo Silva Junior (G)

Public Health and Medical Sciences Graduate Programs, School of Medicine, University of Fortaleza, Fortaleza, Brazil.
MBA in Management, Innovation and Health Services, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.

Giovani Gadonski (G)

MBA in Management, Innovation and Health Services, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
Department of Internal Medicine, School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.

Alejandro Ferreiro Fuentes (A)

School of Medicine, University of the Republic, Montevideo, Uruguay.

Masaomi Nangaku (M)

School of Medicine, The University of Tokyo, Tokyo, Japan.

Giuseppe Remuzzi (G)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

Claudio Ronco (C)

Department of Medicine, University of Padua, Padua, Italy.
International Renal Research Institute of Vicenza, Department of Nephrology, San Bortolo Hospital, Vicenza, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH